Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Morris, M. J.; Heller, G.; Bryce, A. H.; Armstrong, A. J.; Beltran, H.; Hahn, O. M.; McGary, E. C.; Mehan, P. T.; Goldkorn, A.; Roth, B. J.; Xiao, H.; Watt, C.; Hillman, D. W.; Taplin, M. E.; Ryan, C. J.; Halabi, S.; Small, E. J.
Abstract Title:	Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	290s
Language:	English
ACCESSION:	WOS:000487345805416
DOI:	10.1200/JCO.2019.37.15_suppl.5008
PROVIDER:	wos
Notes:	Meeting Abstract: 5008 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156379